[1]
|
Alzheimer’s Disease International Consortium. World Alzheimer Report 2015.
http://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf
|
[2]
|
Blennow, K., de Leon, M.J. and Zetterberg, H. (2006) Alzheimer’s Disease. Lancet, 368, 387-403.
https://doi.org/10.1016/S0140-6736(06)69113-7
|
[3]
|
Gatz, M., Reynolds, C.A., Fratiglioni, L., et al. (2006) Role of Genes and Environments for Explaining Alzheimer Disease. Archives of General Psychiatry, 63, 168-174. https://doi.org/10.1001/archpsyc.63.2.168
|
[4]
|
Liu, C.C., Kanekiyo, T., Xu, H. and Bu, G. (2013) Apolipoprotein E and Alzheimer Disease: Risk, Mechanisms and Therapy. Nature Reviews Neurology, 9, 106-118. https://doi.org/10.1038/nrneurol.2012.263
|
[5]
|
Gispert, J.D., Rami, L., Sanchez-Benavides, G., Falcon, C., Tucholka, A., Rojas, S., et al. (2015) Nonlinear Cerebral Atrophy Patterns across the Alzheimer’s Disease Continuum: Impact of APOE4 Genotype. Neurobiology of Aging, 36, 2687-2701. https://doi.org/10.1016/j.neurobiolaging.2015.06.027
|
[6]
|
Liu, Y., Yu, J.T., Wang, H.F., Han, P.R., Tan, C.C., Wang, C., et al. (2015) APOE Genotype and Neuroimaging Markers of Alzheimer’s Disease: Systematic Review and Meta-Analysis. Journal of Neurology, Neurosurgery, & Psychiatry, 86, 127-134. https://doi.org/10.1136/jnnp-2014-307719
|
[7]
|
Kim, J., Basak, J.M. and Holtzman, D.M. (2009) The Role of Apolipoprotein E in Alzheimer’s Disease. Neuron, 63, 287-303. https://doi.org/10.1016/j.neuron.2009.06.026
|
[8]
|
Heneka, M.T., Carson, M.J., El Khoury, J., Landreth, G.E., Brosseron, F., Feinstein, D.L., et al. (2015) Neuroinflammation in Alzheimer’s Disease. The Lancet Neurology, 14, 388-405. https://doi.org/10.1016/S1474-4422(15)70016-5
|
[9]
|
Atagi, Y., Liu, C.C., Painter, M.M., Chen, X.F., Verbeeck, C., Zheng, H., et al. (2015) Apo Poprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). The Journal of Biological Chemistry, 290, 26043-26050. https://doi.org/10.1074/jbc.M115.679043
|
[10]
|
Getz, G.S. and Reardon, C.A. (2009) Apoprotein E as a Lipid Transport and Signaling Protein in the Blood, Liver, and Artery Wall. The Journal of Lipid Research, 50, S156-S161. https://doi.org/10.1194/jlr.R800058-JLR200
|
[11]
|
Ang, L.S., Cruz, R.P., Hendel, A. and Granville, D.J. (2008) Apolipoprotein E, an Important Player in Longevity and Age-Related Diseases. Experimental Gerontology, 43, 615-622.
|
[12]
|
Matsuura, F., Wang, N., Chen, W., Jiang, X.C. and Tall, A.R. (2006) HDL from CETP-Deficient Subjects Shows Enhanced Ability to Promote Cholesterol Efflux from Macrophages in an apoE- and ABCG1-Dependent Pathway. Journal of Clinical Investigation, 116, 1435-1442. https://doi.org/10.1172/JCI27602
|
[13]
|
Zanotti, I., Pedrelli, M., Pot, F., Stomeo, G., Gomaraschi, M., Calabresi, L. and Bernini, F. (2011) Macrophage, but Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport in Vivo. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 74-80. https://doi.org/10.1161/ATVBAHA.110.213892
|
[14]
|
Eichner, J.E., Dunn, S.T., Perveen, G., Thompson, D.M., Stewart, K.E. and Stroehla, B.C. (2002) Apolipoprotein E Polymorphism and Cardiovascular Disease: A Huge Review. American Journal of Epidemiology, 155, 487-495.
https://doi.org/10.1093/aje/155.6.487
|
[15]
|
Van Oosten, M., Rensen, P.C.N., Van Amersfoort, E.S., Van Eck, M., Van Dam, A.-M., Brev, J.J.P., Vogel, T., Panet, A., Van Berkel, T.J.C. and Kuiper, J. (2001) Apolipoprotein E Protects against Bacterial Lipopolysaccharide-Induced Lethality. A New Therapeutic Approach to Treat Gram-Negative Sepsis. The Journal of Biological Chemistry, 276, 8820-8824. https://doi.org/10.1074/jbc.M009915200
|
[16]
|
Ikeno, Y. (2015) New Insights and Current Concepts of the Oxidative Stress Theory of Aging. Archives of Biochemistry and Biophysics, 576, 1.
|
[17]
|
Tarnus, E., Wassef, H., Carmel, J.F., Rondeau, P., Roche, M., Davignon, J., Bernier, L. and Bourdon, E. (2009) Apolipoprotein E Limits Oxidative Stress-Induced Cell Dysfunctions in Human Adipocytes. FEBS Letters, 583, 2042-2048.
|
[18]
|
Papaioannou, I., Simons, J.P. and Owen, J.S. (2012) Targeted in Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein. Cardiology Research and Practice, 2012, Article ID: 148796.
https://doi.org/10.1155/2012/148796
|
[19]
|
Lee, Y., Kockx, M., Raftery, M.J., Jessup, W., Griffith, R. and Kritharides, L. (2010) Glycosylation and Sialylation of Macrophage-Derived Human Apolipoprotein E Analyzed by SDS-PAGE and Mass Spectrometry: Evidence for a Novel Site of Glycosylation on Ser290. Molecular & Cellular Proteomics, 9, 1968-1981.
https://doi.org/10.1074/mcp.M900430-MCP200
|
[20]
|
Singh, P.P., Singh, M. and Mastana, S.S. (2006) APOE Distribution in World Populations with New Data from India and the UK. Annals of Human Biology, 33, 279-308. https://doi.org/10.1080/03014460600594513
|
[21]
|
Frieden, C. and Garai, K. (2012) Structural Differences between apoE3 and apoE4 May Be Useful in Developing Therapeutic Agents for Alzheimer’s Disease. Proceedings of the National Academy of Sciences, 109, 8913-8918.
https://doi.org/10.1073/pnas.1207022109
|
[22]
|
Dong, L.M., Wilson, C., Wardell, M.R., Simmons, T., Mahley, R.W., Weisgraber, K.H. and Agard, D.A. (1994) Human Apolipoprotein E. Role of Arginine 61 in Mediating the Lipoprotein Preferences of the E3 and E4 Isoforms. The Journal of Biological Chemistry, 269, 22358-22365.
|
[23]
|
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. (1993) Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer’s Disease in Late Onset Families. Science, 261, 921-923. https://doi.org/10.1126/science.8346443
|
[24]
|
Miyata, M. and Smith, J.D. (1996) Apolipoprotein E Allele-Specific Antioxidant Activity and Effects on Cytotoxicity by Oxidative Insults and Beta-Amyloid Peptides. Nature Genetics, 14, 55-61. https://doi.org/10.1038/ng0996-55
|
[25]
|
Jofre-Monseny, L., Minihane, A.M. and Rimbach, G. (2008) Impact of apoE Genotype on Oxidative Stress, Inflammation and Disease Risk. Molecular Nutrition & Food Research, 52, 131-145. https://doi.org/10.1002/mnfr.200700322
|
[26]
|
Pocernich, C.B., Sultana, R., Hone, E., Turchan, J., Martins, R.N., Calabrese, V., Nath, A. and Butterfield, D.A. (2004) Effects of Apolipoprotein E on the Human Immunodeficiency Virus Protein Tat in Neuronal Cultures and Synaptosomes. Journal of Neuroscience Research, 77, 532-539. https://doi.org/10.1002/jnr.20182
|
[27]
|
Jofre-Monseny, L., de Pascual-Teresa, S., Plonka, E., Huebbe, P., Boesch-Saadatmandi, C., Minihane, A.M. and Rimbach, G. (2007) Differential Effects of Apolipoprotein E3 and E4 on Markers of Oxidative Status in Macrophages. British Journal of Nutrition, 97, 864-871. https://doi.org/10.1017/S0007114507669219
|
[28]
|
Jofre-Monseny, L., Huebbe, P., Stange, I., Boesch-Saadatmandi, C., Frank, J., Jackson, K., Minihane, A.-M. and Rimbach, G. (2008) Influence of Apolipoprotein E Genotype and Dietary Alpha-Tocopherol on Redox Status and C-Reactive Protein Levels in Apolipoprotein E3 and E4 Targeted Replacement Mice. British Journal of Nutrition, 100, 44-53. https://doi.org/10.1017/S000711450788634X
|
[29]
|
Talmud, P.J., Stephens, J.W., Hawe, E., Demissie, S., Cupples, L.A., Hurel, S.J., Humphries, S.E. and Ordovas, J.M. (2005) The Significant Increase in Cardiovascular Disease Risk in APOE 4 Carriers Is Evident Only in Men Who Smoke: Potential Relationship between Reduced Antioxidant Status and ApoE4. Annals of Human Genetics, 69, 613-622. https://doi.org/10.1111/j.1529-8817.2005.00205.x
|
[30]
|
Holmes, M.V., Frikke-Schmidt, R., Melis, D., Luben, R., Asselbergs, F.W., Boer, J.M.A., Cooper, J., Palmen, J., Horvat, P., Engmann, J., Li, K.W., Onland-Moret, N.C., Hofker, M.H., Kumari, M., Keating, B.J., Hubacek, J.A., Adamkova, V., Kubinova, R., Bobak, M., Khaw, K.T., Nordestgaard, B.G., Wareham, N., Humphries, S.E., Langenberg, C., Tybjaerg-Hansen, A. and Talmud, P.J. (2014) A Systematic Review and Meta-Analysis of 130,000 Individuals Shows Smoking Does Not Modify the Association of APOE Genotype on Risk of Coronary Heart Disease. Atherosclerosis, 237, 5-12.
|
[31]
|
Ramassamy, C., Averill, D., Beffert, U., Theroux, L., Lussier-Cacan, S., Cohn, J.S., Christen, Y., Schoofs, A., Davignon, J. and Poirier, J. (2000) Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer’s Disease Brain. Neurobiology of Disease, 7, 23-37. https://doi.org/10.1006/nbdi.1999.0273
|
[32]
|
Graeser, A.C., Huebbe, P., Storm, N., Höppner, W., Döring, F., Wagner, A.E. and Rimbach, G. (2012) Apolipoprotein E Genotype Affects Tissue Metallothionein Levels: Studies in Targeted Gene Replacement Mice. Genes & Nutrition, 7, 247-255. https://doi.org/10.1007/s12263-012-0282-x
|
[33]
|
Boesch-Saadatmandi, C., Niering, J., Minihane, A.M., Wiswedel, I., Gardeman, A., Wolffram, S. and Rimbach, G. (2010) Impact of Apolipoprotein E Genotype and Dietary Quercetin on Paraoxonase 1 Status in apoE3 and apoE4 Transgenic Mice. Atherosclerosis, 211, 110-113.
|
[34]
|
Gaidukov, L., Viji, R.I., Yacobson, S., Rosenblat, M., Aviram, M. and Tawfik, D.S. (2010) ApoE Induces Serum Paraoxonase PON1 Activity and Stability Similar to ApoA-I. Biochemistry, 49, 532-538.
https://doi.org/10.1021/bi9013227
|
[35]
|
Ross, J.M., Olson, L. and Coppotelli, G. (2015) Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin? International Journal of Molecular Sciences, 16, 19458-19476.
https://doi.org/10.3390/ijms160819458
|
[36]
|
Bravo, R., Gutierrez, T., Paredes, F., Gatica, D., Rodriguez, A.E., Pedrozo, Z., Chiong, M., Parra, V., Quest, A.F.G., Rothermel, B.A. and Lavandero, S. (2012) Endoplasmic Reticulum: ER Stress Regulates Mitochondrial Bioenergetics. The International Journal of Biochemistry & Cell Biology, 44, 16-20.
|
[37]
|
Brewer, J.W. (2014) Regulatory Crosstalk within the Mammalian Unfolded Protein Response. Cellular and Molecular Life Sciences, 71, 1067-1079. https://doi.org/10.1007/s00018-013-1490-2
|
[38]
|
Cao, S.S. and Kaufman, R.J. (2014) Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease. Antioxidants & Redox Signaling, 21, 396-413. https://doi.org/10.1089/ars.2014.5851
|
[39]
|
Zhong, N., Ramaswamy, G. and Weisgraber, K.H. (2009) Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function. The Journal of Biological Chemistry, 284, 27273-27280.
https://doi.org/10.1074/jbc.M109.014464
|
[40]
|
Zhong, N., Ramaswamy, G., Weisgraber, K.H. (2009) Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function. The Journal of Biological Chemistry, 284, 27273-27280.
|
[41]
|
Brodbeck, J., McGuire, J., Liu, Z., Meyer-Franke, A., Balestra, M.E., Jeong, D.E., Pleiss, M., McComas, C., Hess, F., Witter, D., Peterson, S., Childers, M., Goulet, M., Liverton, N., Hargreaves, R., Freedman, S., Weisgraber, K.H., Mahley, R.W. and Huang, Y. (2011) Structure-Dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-Molecule Structure Correctors. The Journal of Biological Chemistry, 286, 17217-17226. https://doi.org/10.1074/jbc.M110.217380
|
[42]
|
Segev, Y., Michaelson, D.M. and Rosenblum, K. (2013) ApoE 4 Is Associated with eIF2 Phosphorylation and Impaired Learning in Young Mice. Neurobiology of Aging, 34, 863-872.
|
[43]
|
Eberl, D., Kim, R.Y., Luk, F.S., De Mochel, N.S.R., Gaudreault, N., Olivas, V.R., Kumar, N., Posada, J.M., Birkeland, A.C., Rapp, J.H. and Raffai, R.L. (2012) Apolipoprotein E4 Domain Interaction Accelerates Diet-Induced Atherosclerosis in Hypomorphic Arg-61 Apoe Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 32, 1116-1123.
https://doi.org/10.1161/ATVBAHA.112.246389
|
[44]
|
Sabaretnam, T., Harris, J.M., Kockx, M., Witting, P.K., Le Couteur, D.G. and Kritharides, L. (2009) Effects of Hydrogen Peroxide and Apolipoprotein E Isoforms on Apolipoprotein E Trafficking in HepG2 Cells. Clinical and Experimental Pharmacology and Physiology, 36, 96-102. https://doi.org/10.1111/j.1440-1681.2009.05306.x
|
[45]
|
Simpson, J.E., Ince, P.G., Shaw, P.J., Heath, P.R., Raman, R., Garwood, C.J., Gelsthorpe, C., Baxter, L., Forster, G., Matthews, F.E., Brayne, C. and Wharton, S.B. (2011) Microarray Analysis of the Astrocyte Transcriptome in the Aging Brain: Relationship to Alzheimer’s Pathology and APOE Genotype. Neurobiology of Aging, 32, 1795-1807.
|
[46]
|
Nunnari, J. and Suomalainen, A. (2012) Mitochondria: In Sickness and in Health. Cell, 148, 1145-1159.
|
[47]
|
Lopez-Mejia, I.C. and Fajas, L. (2015) Cell Cycle Regulation of Mitochondrial Function. Current Opinion in Cell Biology, 33, 19-25.
|
[48]
|
Chen, H.K., Ji, Z.S., Dodson, S.E., Miranda, R.D., Rosenblum, C.I., Reynolds, I.J., Freedman, S.B., Weisgraber, K.H., Huang, Y. and Mahley, R.W. (2011) Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease. The Journal of Biological Chemistry, 286, 5215-5221. https://doi.org/10.1074/jbc.M110.151084
|
[49]
|
Mosconi, L., Nacmias, B., Sorbi, S., De Cristofaro, M.T.R., Fayazz, M., Tedde, A., Bracco, L., Herholz, K. and Pupi, A. (2004) Brain Metabolic Decreases Related to the Dose of the ApoE e4 Allele in Alzheimer’s Disease. Journal of Neurology, Neurosurgery, & Psychiatry, 75, 370-376. https://doi.org/10.1136/jnnp.2003.014993
|
[50]
|
Mosconi, L., Herholz, K., Prohovnik, I., Nacmias, B., De Cristofaro, M.T.R., Fayyaz, M., Bracco, L., Sorbi, S. and Pupi, A. (2005) Metabolic Interaction between ApoE Genotype and Onset Age in Alzheimer’s Disease: Implications for Brain Reserve. Journal of Neurology, Neurosurgery, & Psychiatry, 76, 15-23.
https://doi.org/10.1136/jnnp.2003.030882
|
[51]
|
Tamboli, I.Y., Heo, D. and Rebeck, G.W. (2014) Extracellular Proteolysis of Apolipoprotein E (apoE) by Secreted Serine Neuronal Protease. PLoS ONE, 9, e93120. https://doi.org/10.1371/journal.pone.0093120
|
[52]
|
Xu, H., Gupta, V.B., Martins, I.J., Martins, R.N., Fowler, C.J., Bush, A.I., Finkelstein, D.I. and Adlard, P.A. (2015) Zinc Affects the Proteolytic Stability of Apolipoprotein E in an Isoform-Dependent Way. Neurobiology of Disease, 81, 38-48.
|
[53]
|
Nakamura, T., Watanabe, A., Fujino, T., Hosono, T. and Michikawa, M. (2009) Apolipoprotein E4 (1-272) Fragment Is Associated with Mitochondrial Proteins and Affects Mitochondrial Function in Neuronal Cells. Molecular Neurodegeneration, 4, 35. https://doi.org/10.1186/1750-1326-4-35
|
[54]
|
Chin, D., Hagl, S., Hoehn, A., Huebbe, P., Pallauf, K., Grune, T., Frank, J., Eckert, G.P. and Rimbach, G. (2014) Adenosine Triphosphate Concentrations Are Higher in the Brain of APOE3-Compared to APOE4-Targeted Replacement Mice and Can Be Modulated by Curcumin. Genes & Nutrition, 9, 397. https://doi.org/10.1007/s12263-014-0397-3
|
[55]
|
Su, B., Wang, X., Bonda, D., Perry, G., Smith, M. and Zhu, X. (2010) Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer’s Disease? Molecular Neurobiology, 41, 87-96.
https://doi.org/10.1007/s12035-009-8095-7
|
[56]
|
Yu, C.E., Seltman, H., Peskind, E.R., Galloway, N., Zhou, P.X., Rosenthal, E., Wijsman, E.M., Tsuang, D.W., Devlin, B. and Schellenberg, G.D. (2007) Comprehensive Analysis of APOE and Selected Proximate Markers for Late-Onset Alzheimer’s Disease: Patterns of Linkage Disequilibrium and Disease/Marker Association. Genomics, 89, 655-665.
|
[57]
|
Chaudhari, N., Talwar, P., Parimisetty, A., Lefebvre d’Hellencourt, C. and Ravanan, P. (2014) A Molecular Web: Endoplasmic Reticulum Stress, Inflammation and Oxidative Stress. Frontiers in Cellular Neuroscience, 8, 213.
https://doi.org/10.3389/fncel.2014.00213
|
[58]
|
Zhang, H., Wu, L.M. and Wu, J. (2011) Cross-Talk between Apolipoprotein e and Cytokines. Mediators of Inflammation, 2011, Article ID: 949072. https://doi.org/10.1155/2011/949072
|
[59]
|
Li, X., Montine, K.S., Keene, C.D. and Montine, T.J. (2015) Different Mechanisms of Apolipoprotein E Isoform-Dependent Modulation of Prostaglandin E2 Production and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Expression after Innate Immune Activation of Microglia. The FASEB Journal, 29, 1754-1762.
https://doi.org/10.1096/fj.14-262683
|
[60]
|
Vitek, M.P., Brown, C.M. and Colton, C.A. (2009) APOE Genotype-Specific Differences in the Innate Immune Response. Neurobiology of Aging, 30, 1350-1360.
|